Bladder cancer is a common type of cancer that affects the bladder's lining. Treatment options vary depending on the stage and grade of the cancer. One innovative approach is intravesical therapy, which involves delivering medication directly into the bladder.

What is Intravesical Therapy?

Intravesical therapy is a specialized treatment where drugs are instilled directly into the bladder through a catheter. This method allows high concentrations of medication to target cancer cells while minimizing systemic side effects.

Types of Intravesical Treatments

  • Immunotherapy: Bacillus Calmette-Guérin (BCG) is the most common immunotherapy used. It stimulates the immune system to attack cancer cells.
  • Chemotherapy: Drugs like mitomycin C are used to kill cancer cells directly within the bladder.

How the Treatment is Administered

The procedure involves inserting a catheter into the bladder, filling it with the medication, and then retaining the drug for a specified period. Patients usually undergo multiple sessions over weeks or months, depending on their treatment plan.

Advantages of Intravesical Therapy

  • Targets cancer cells directly within the bladder
  • Reduces systemic side effects compared to oral or intravenous treatments
  • Can be used to prevent recurrence after surgery

Potential Side Effects

While generally well-tolerated, intravesical therapy may cause side effects such as bladder irritation, urinary frequency, or mild flu-like symptoms, especially with BCG treatment. Most side effects are temporary and manageable.

Conclusion

Intravesical therapy represents a targeted and effective treatment option for bladder cancer, especially in early stages. Understanding how it works and its benefits can help patients and healthcare providers make informed decisions about cancer management.